SUNITINIB Teva caps 50 mg 28 pce

7680677810046 CH-67781 L01XE04 07.16.1.

Reimbursement limitations:

SUTENT

Traitement de patients atteints de tumeurs stromales gastro-intestinales malignes (GIST) en cas de résistance ou …

SUNITINIB Teva caps 50 mg 28 pce
SUNITINIB Teva caps 50 mg 28 pce
SUNITINIB Teva caps 50 mg 28 pce
1 / 3
google

Details

Product number
6778104
CPT
-
Packaging group
28
Unit
Kapsel(n)
Composition
sunitinibum 50 mg, mannitolum, povidonum K 25, carmellosum natricum conexum corresp. natrium max. 0.31 mg, magnesii stearas, Kapselhülle: gelatina, E 171, E 172 (rubrum), E 172 (flavum), Drucktinte: lacca, E 172 (nigrum), propylenglycolum, ammoniae solutio concentrata, kalii hydroxidum, pro capsula.

Articles (1)

Sunitinib-Teva 50 mg, Hartkapseln
Kapseln
28
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
07/12/2024
Patient information leaflet
Français
07/12/2024
Patient information leaflet
Italien
07/12/2024
Professional SmPC
Allemand
07/12/2024
Professional SmPC
Français
07/12/2024
Professional SmPC
Italien
07/12/2024

Detailed composition

Substance Quantity Type Category
(N/A)
50.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK
(N/A)
- Substance FTODK
(N/A)
- Substance FTODK
(N/A)
- Substance HNIDK
(N/A)
- Substance FTODK
(N/A)
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 3329.50
Specialties list
Yes
Generic
Yes

Reimbursement limitation

SL addition date: 01/11/2021

Authorization holder

Teva Pharma AG

4051 Basel

Authorization information

Swissmedic authorization number
67781
Drug name
Sunitinib-Teva, Hartkapseln
Galenic form
KAHA
ATC Code
L01EX01
Authorization status
Z
Dispensation category
A
First authorization
15/02/2021
Authorization expiration date
31/12/9999
IT number
07.16.1.
Domain
Human medicine
Field of application
Zytostatikum

Packaging details

Description (FR)
SUNITINIB Teva caps 50 mg 28 pce
Description (DE)
SUNITINIB Teva Kaps 50 mg 28 Stk
Market launch
15/02/2021
Narcotic (BTM)
No

Original drug

Sutent, Hartkapseln
CHF 969.50
View original

Other packaging sizes

SUNITINIB Teva caps 12.5 mg 28 pce
28 KAP
View
SUNITINIB Teva caps 25 mg 28 pce
28 KAP
View